Descrizione

Retinal imaging involves creating a two-dimensional image of the three-dimensional (3D) retinal tissue. Such retinal imaging techniques are indispensable for diagnosis and management of disease processes in ophthalmic practice. These help ophthalmic practitioners directly to view the retinal disease and plan treatment according to the pathology. The global retinal imaging devices market is poised to grow by US$ 831.2 milioni durante 2022-2028, procedendo a un CAGR di 5.1% durante il periodo di previsione, secondo la società di dati e analisi StrategyHelix.

Il rapporto fornisce dati aggiornati sulle dimensioni del mercato per il periodo 2018-2021 e previsione a 2028 covering key market aspects like sales value for retinal imaging devices. The global retinal imaging devices market is segmented on the basis of product, end user, e regione. Per prodotto, the global retinal imaging devices market has been segmented into fluorescein angiography, fundus camera, optical coherence tomography (OCT). Secondo la ricerca, the fundus camera segment had the largest share in the global retinal imaging devices market. Based upon end user, the global retinal imaging devices market is categorized into ambulatory surgical centers (ASCs), ospedali & clinics, ophthalmic centers, altri. Geograficamente, the global retinal imaging devices market is segmented into North America, Asia Pacifico, Europa, Rest of the World (ROW).

The global retinal imaging devices market is highly competitive. The leading players in the retinal imaging devices market include Carl Zeiss Meditec, Epipole Ltd., Eyenuk Inc., Forus Health Pvt. Ltd., Imagine Eyes SA, Nikon Corporation (Optos plc), Olympus Corporation, Optomed PLC, Revenio Group Oyj (CenterVue SpA), Robert Bosch GmbH, Topcon Corporation.

Il rapporto è una risorsa inestimabile per le aziende e le organizzazioni attive in questo settore. It provides a cohesive picture of the retinal imaging devices market to help drive informed decision making for industry executives, decisori politici, accademico, e analisti.

Ambito del rapporto

Prodotto: fluorescein angiography, fundus camera, optical coherence tomography (OCT)
Utente finale: ambulatory surgical centers (ASCs), ospedali & clinics, ophthalmic centers, altri
Regione: Nord America, Asia Pacifico, Europa, Rest of the World (ROW)
Anni considerati: la presente relazione copre il periodo 2018 A 2028

Principali vantaggi per gli stakeholder

– Get a comprehensive picture of the global retinal imaging devices market
– Individuare i settori in crescita e le tendenze per gli investimenti

Sommario

Parte 1. introduzione
– Ambito dello studio
– Periodo di studio
– Ambito geografico
– Metodologia di ricerca
Parte 2. Retinal imaging devices market overview
Parte 3. Ripartizione del mercato per prodotto
– Fluorescein angiography
– Fundus camera
– Optical coherence tomography (OCT)
Parte 4. Market breakdown by end user
– Ambulatory surgical centers (ASCs)
– Ospedali & clinics
– Ophthalmic centers
– Altri
Parte 5. Market breakdown by region
– Nord America
– Asia Pacifico
– Europa
– Rest of the World (ROW)
Parte 6. Aziende chiave
– Carl Zeiss Meditec
– Epipole Ltd.
– Eyenuk Inc.
– Forus Health Pvt. Ltd.
– Imagine Eyes SA
– Nikon Corporation (Optos plc)
– Olympus Corporation
– Optomed PLC
– Revenio Group Oyj (CenterVue SpA)
– Robert Bosch GmbH
– Topcon Corporation
Informazioni su StrategyHelix
Disclaimer